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Abstract
Introduction: Acute renal failure caused by nonsteroidal anti-inflammatory drugs administered at
therapeutic doses is generally mild, non-anuric and transitory. There are no publications on
indomethacin toxicity secondary to high doses in children. The aim of this article is to describe
acute renal failure secondary to a high dose of indomethacin in a child and to review an error in a
supervised drug prescription and administration system.
Case presentation: Due to a medication error, a 20-day-old infant in the postoperative period
of surgery for Fallot's tetralogy received a dose of 10 mg/kg of indomethacin, 50 to 100 times higher
than the therapeutic dose. The child presented with acute, oligo-anuric renal failure requiring
treatment with continuous venovenous renal replacement therapy, achieving complete recovery of
renal function with no sequelae.
Conclusion: In order to reduce medication errors in critically ill children, it is necessary to
develop a supervised drug prescription and administration system, with controls at various levels.
Introduction
Drug toxicity causes 2% to 5% of hospital admissions
[1,2]. In addition, between 7% and 10% of hospitalized
patients suffer adverse drug reactions [2]. These reactions
may be related to the drug (toxic potential, dose, duration,
route of administration and interactions with other drugs)
or to the patient (age, sex, metabolic abnormalities or
associated pathology that could alter drug metabolism
and/or excretion). For these reasons, adverse drug reac-
tions are more common in critically ill patients [3].
Many drugs cause renal toxicity. The lesion most com-
monly develops in the tubules and interstitium but can
also affect the glomerulus or intrarenal blood vessels [4].
The risk of drug-induced renal toxicity is higher in chil-
dren as the glomerular filtration rate is lower and the kid-
neys have an immature enzyme system. The accidental,
voluntary or iatrogenic administration of drug overdoses
is a relatively common cause of acute renal failure (ARF)
[5]. In children, although the most common causes of
ARF are ischemia after cardiac surgery, sepsis and the
hemolytic uremic syndrome, drug toxicity can account for
up to 16% of cases [6].
Nonsteroidal anti-inflammatory drugs (NSAIDs), includ-
ing indomethacin, cause renal toxicity by inhibiting the
enzyme cyclooxygenase in the glomerulus, producing
vasoconstriction [4,5,7,8]. Acute renal failure caused by
the NSAIDs administered at therapeutic doses is an under-
estimated complication as it is usually mild, transitory
and non-anuric. In premature neonates, it has been esti-
mated that therapeutic doses of indomethacin give rise to
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transitory renal toxicity in 24% of cases [9]. However, in
the literature, we have found no case reports of acute renal
failure in children secondary to the administration of a
high dose of indomethacin.
Case presentation
The patient was a 20-day-old Spanish male infant with a
body weight of 2.5 kg, transferred from the neonatal unit
on the ninth day after the surgical correction of Fallot's
tetralogy and pulmonary atresia. On admission to the
pediatric intensive care unit, the infant required mechan-
ical ventilation, an infusion of vasoactive drugs
(dopamine 6 mcg/kg/minute, dobutamine 10 mcg/kg/
minute and milrinone 0.5 mcg/kg/minute) and furosem-
ide in a continuous infusion of 0.4 mg/kg/hour. The
patient had received treatment with vancomycin and ami-
kacin up to 2 days earlier. On examination, there was
marked generalized edema. The initial blood tests
revealed a creatinine level of 0.5 mg/dL, urea 75 mg/dL,
albumin 2.8 g/dL, sodium 132 mmol/L, potassium 4.6
mmol/L and chloride 96 mmol/L. In order to decrease the
doses of intravenous vasoactive drugs, it was decided to
administer digitalis to the patient, prescribing a dose of
digoxin of 10 mcg/kg enterally. Four hours after the
administration of the drug, the child presented with pro-
gressive oliguria, with a fall in diuresis from 4 to 1.5 mL/
kg/hour, and with no change in the hemodynamic situa-
tion (blood pressure 65/40 mmHg, lactate 1.1 mmol/L,
heart rate 140 bpm). Blood tests revealed a rise in creati-
nine to 0.7 mg/dL and in urea to 89 mg/dL and a fall in
sodium to 121 mmol/L. There were no neurological clin-
ical symptoms or alterations in the cerebral echography
that suggested cerebral edema. The urinalysis was normal.
Initially, to exclude hypovolemia, volume expansion was
performed with 5% albumin (20 mL/kg). Intravenous
sodium replacement was started according to the equa-
tion (135 - 121) × 0.6 × weight (kg) in 24 hours and the
dose of dopamine was increased from 7.5 to 15 mcg/kg/
minute in order to raise the mean blood pressure and
improve renal perfusion. Subsequently, on persistence of
the oliguria, the infusion of furosemide was increased
from 0.4 to 1 mg/kg/hour, though no improvement in the
diuresis was achieved. The medication chart was reviewed
and the error was detected. Instead of digoxin, indometh-
acin had been prescribed at a dose of 25 mg (10 mg/kg),
which is 50 to 100 times higher than the therapeutic dose.
Initially, it was decided to maintain a conservative
approach. The child remained hemodynamically stable
but presented with anuria and an increase in edema; con-
tinuous venovenous hemofiltration was therefore started
after 12 hours. This therapy was continued for 33 hours,
with a negative balance of 25 mL/hour, after which diure-
sis and renal function recovered (Table 1). The subse-
quent course was favorable and the infant was discharged
from the pediatric intensive care unit with a creatinine
level of 0.2 mg/dL, urea 15 mg/dL and normal diuresis.
No alteration of renal function has been detected on sub-
sequent follow-up.
Discussion
NSAIDs are a relatively common cause of renal toxicity in
the adult [4,6]. These drugs can lead to renal failure
through various mechanisms: the most important of these
is the decrease in the levels of prostaglandins, which regu-
late arterial and glomerular vasodilatation, though they
can also produce acute tubular necrosis due to direct tox-
icity or to acute interstitial nephritis [4,5,7,8].
Indomethacin is a drug that is not commonly used in chil-
dren. However, it is the treatment of choice in patent duc-
tus arteriosus in the premature newborn infant. In these
cases, treatment at a dose of 0.1 mg/kg every 24 hours for
6 days has been reported to be associated with an increase
in creatinine levels in up to 24% of patients between the
second and seventh days of treatment, with complete
recovery of renal function at 30 days [9]. We have found
no previous cases of the administration of massive doses
of indomethacin in children.
There is a higher risk of drug-induced nephrotoxicity in
critically ill patients due to the frequent association with
other factors such as pre-existing renal failure or renovas-
cular disease, the presence of secondary hypovolemia,
hypertension, cardiac failure, hypoalbuminemia, electro-
lyte disturbances, hepatic disorders affecting metabolism,
and the administration of other drugs that interfere with
the metabolism and/or potentiate the nephrotoxicity of
indomethacin [10]. In our patient, the administration of
Table 1: Evolution of analytical data
Admission to the PICU Start of CRRT End of CRRT
Na (mmol/L) 132 121 129
K (mmol/L) 4.6 4.1 2.9
Urea (mg/dL) 57 89 34
Creatinine (mg/dL) 0.5 0.7 0.4
Urine output (mL/kg/hour) 4.5 0 3
PICU, pediatric intensive care unit; CRRT, continuous renal replacement therapy.Journal of Medical Case Reports 2009, 3:47 http://www.jmedicalcasereports.com/content/3/1/47
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indomethacin at a dose 100 times higher than the thera-
peutic dose was associated with several factors that could
have increased its toxicity, such as renal immaturity due to
age and cardiac failure secondary to surgery for the con-
genital cardiopathy, in addition to edema, hypoalbu-
minemia and the administration of high doses of
furosemide.
In our patient, the indomethacin-induced nephrotoxicity
led to anuria, requiring the early initiation of continuous
renal replacement therapy as hypervolemia secondary to
anuria could have led to significant hemodynamic
decompensation in a patient who had recently undergone
cardiac surgery. In the majority of cases of ARF associated
with therapeutic doses of NSAIDs published in the litera-
ture, renal function recovered completely within a short
period of time [4,7]. Recently, it has been suggested that
children who develop ARF have a higher morbidity and
mortality and more long-term renal sequelae [11]. How-
ever, in our patient, despite the severity of the ARF, recov-
ery of renal function was complete within a few days.
Various studies have demonstrated that a significant
number of errors in the prescription and/or administra-
tion of medication occur in intensive care units due, in
part, to the large number of drugs used, the need for rapid
action, and an overburdening of resources [12,13].
Although the majority are relatively unimportant, some
can put the patient's life at risk [12,13]. The existence of a
supervision system is therefore essential. In our hospital,
there is a computerized therapeutic prescription program,
with a system of dose error alarms. It is routinely the resi-
dent who writes the prescription and this is supervised by
the staff physician and confirmed by the nurse responsi-
ble for the patient. However, in this patient, the erroneous
prescription written by the resident was not detected by
the Pharmacy's computerized system and was not checked
by the staff physician. The nurse requested confirmation
of the drug and dose and this was given by the resident.
Although computerized prescription systems have been
shown to reduce the number of errors [14,15], it is impor-
tant to monitor drug prescription and administration at
various levels in order to prevent errors; this should
involve not only computer systems but also control by the
pharmacy staff and, principally, by the medical and nurs-
ing staff. Furthermore, if possible, the use of nephrotoxic
drugs should be avoided, particularly in combination;
when their administration is unavoidable, the need for
monitoring of blood levels and for periodic controls of
renal function to adjust the dose should be evaluated.
Conclusion
We conclude that indomethacin at very high doses causes
transitory acute renal failure. To reduce medication errors
in critically ill children, it is necessary to develop a super-
vised drug prescription and administration system with
controls at various levels.
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